• Aethlon Medical Announces U.S. FDA Approval of Hemopurifier COVID-19 Study Protocol Amendment

    1 month ago - By San Diego Biotechnology

    Approval eliminates the requirement for previous dialysis treatment, potentially enabling accelerated enrollment in the ongoing clinical study SAN DIEGO, July 11, 2022 /PRNewswire/ - Aethlon Medical, Inc. , a medical therapeutic company focused on...
    Read more ...

     

  • Ionis partner licenses rare kidney disease treatment and will advance into Phase 3 clinical study

    1 month ago - By San Diego Biotechnology

    Positive data from a Phase 2 study of IONIS-FB-LRx support further development for treatment of patients with IgA nephropathy CARLSBAD, Calif., July 11, 2022 /PRNewswire/ - Ionis Pharmaceuticals, Inc. , today announced that...
    Read more ...